Clozapine

CAS 5786-21-0 12 current records 4 historicalSmall Molecule

Who holds supplier records for Clozapine? 12 organisations hold a current record for Clozapine: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), China (2), Italy (1) and Spain (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Clozapine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/clozapine

Reading the evidence

  • 12 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    7 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Clozapine expires 1 May 2028. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (12)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Clozapine. Country is the organisation's recorded country, not necessarily the manufacturing site.

India7China2Italy1Spain1Country not recorded for 1
Need Clozapine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Clozapine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
AURORE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2023-444 - Rev 01
Clozapine, Site Khazipally
Aug 2026—
MANKIND PHARMA LIMITED New DelhiIN
CEP 2024-575 - Rev 00
Clozapine, Micronised
Aug 2026—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2008-234 - Rev 03
Clozapine
Dec 2025—
Global Calcium Private Limited HosurIN
CEP 2022-328 - Rev 00
Clozapine
Dec 2024Inspected Sept 2024
France
Cambrex Profarmaco Milano S.r.l. PaulloIT
R1-CEP 2005-128 - Rev 03
Clozapine
May 2022—
WUHAN SHIJI PHARMACEUTICAL CO., LTD. WuhanCN
R1-CEP 2010-087 - Rev 01
Clozapine
Apr 2019—
SHOUGUANG FUKANG PHARMACEUTICAL CO., LTD. Shouguang CityCN
R1-CEP 2012-006 - Rev 00
Clozapine
Apr 2018—
Medichem, S.A. Sant Joan DespíES
R1-CEP 2008-151 - Rev 00
Clozapine
Jul 2015—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Clozapine are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • HUIZHOU DONGJIANG PHARMACEUTICAL FACTORY GUANGDONG
    Inactive DMF 12873 · filed Feb 1998
  • SELOC FRANCE
    Inactive DMF 12401 · filed Mar 1997
  • SANDOZ LTD PHARMACEUTICAL DIV CHEMICAL DEVELOPMENT
    Inactive DMF 11098 · filed Sept 1994
  • Germany · Inactive DMF 10862 · filed Apr 1994

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (34 listed products contain Clozapine). The latest listed patent expires 1 May 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Clozapine is an atypical antipsychotic used for the treatment of resistant schizophrenia and for reducing the risk of suicidal behavior in people with schizophrenia. It works by blocking various neurotransmitter receptors in the brain, particularly serotonin and dopamine receptors.

Chemical identity

IUPAC name
3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine
Canonical SMILES
CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42
InChIKey
QZUDBNBUXVUHMW-UHFFFAOYSA-N
Synonyms
Clozaril API, clozapine (caraco), clozapine (clozaril), clozapine (fazaclo), clozapine (ivax), clozapine (mylan), clozapine (teva), clozapine (udl), clozapine (versacloz), clozapine resolution mixture, clozaril, fazaclo

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Atypical Antipsychotic

Therapeutic areas

PsychiatryNeurologySchizophrenia

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Clozapine?

12 organisations hold an active US FDA Type II Drug Master File or a CEP for Clozapine: Aurore Life Sciences (India), CAMBREX PROFARMACO MILANO SRL (Italy), GLOBAL CALCIUM PRIVATE LTD (India), Mankind Pharma Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), MEDICHEM SA (Spain), SHOUGUANG FUKANG PHARMACEUTICAL CO LTD (China) and WUHAN SHIJI PHARMACEUTICAL CO LTD, and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Clozapine Drug Master Files are active?

Aurore Life Sciences (DMF 36645), CAMBREX PROFARMACO MILANO SRL (DMF 11692), GLOBAL CALCIUM PRIVATE LTD (DMF 36869), Mankind Pharma Limited (DMF 37540), MATRIX PHARMACORP PRIVATE LTD (DMF 27379), MEDICHEM SA (DMF 10534), SHOUGUANG FUKANG PHARMACEUTICAL CO LTD (DMF 25182) and WUHAN SHIJI PHARMACEUTICAL CO LTD (DMF 19822) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Clozapine records mean?

4 organisations have only inactive Type II DMFs for Clozapine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Clozapine have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Clozapine on the EDQM register, including AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), MANKIND PHARMA LIMITED New Delhi (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), Global Calcium Private Limited Hosur (IN), Cambrex Profarmaco Milano S.r.l. Paullo (IT) and WUHAN SHIJI PHARMACEUTICAL CO., LTD. Wuhan (CN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Clozapine?

Yes. The latest patent listed for an approved US product containing Clozapine expires 1 May 2028, across 34 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Clozapine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Clozapine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.